Related Experiment Video
Updated: Oct 8, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas
G Nagashima1, M Aoyagi, S Yamamoto
1Department of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan. goro-n@po1.dti2.ne.jp
Abstract:
We investigated the expression of c-myc and c-sis/PDGF mRNA and protein products in 20 cases of meningiomas of various grades: 10 benign, 5 atypical and 5 anaplastic meningiomas. All cases of atypical and anaplastic meningiomas were positive for c-myc protein and mRNA by immunohistochemistry and in situ hybridisation, respectively, while all 10 benign meningiomas were negative for c-myc immunostaining, with only one benign tumour positive for c-myc mRNA. Expression of PDGF-BB protein and c-sis mRNA were seen in more than 80% of the meningioma cases and was not restricted to the histological grades of meningiomas. Semiquantitative analysis showed that the frequency of c-myc immunopositive cells positively correlated with Ki-67 proliferative indices. Our findings suggest that c-myc, but not c-sis/PDGF, has some concern to the malignancy of meningiomas.
Insights
This study found that c-myc expression is linked to meningioma malignancy, unlike c-sis/PDGF. C-myc protein and mRNA were detected in higher-grade meningiomas, correlating with proliferation markers.
Area of Science:
- Oncology
- Molecular Biology
- Neurosurgery
Background:
- Meningiomas are tumors arising from the meninges.
- Understanding molecular markers associated with meningioma grade is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the expression of c-myc and c-sis/platelet-derived growth factor (PDGF) in meningiomas of varying grades.
- To determine the correlation between these markers and tumor malignancy.
Main Methods:
- Examined 20 meningioma cases (10 benign, 5 atypical, 5 anaplastic).
- Utilized immunohistochemistry and in situ hybridization to detect c-myc and c-sis/PDGF mRNA and protein.
- Assessed Ki-67 proliferative indices.
Main Results:
- C-myc protein and mRNA were present in all atypical and anaplastic meningiomas, but absent in most benign cases.
- PDGF-BB protein and c-sis mRNA were found in over 80% of all meningioma grades.
- C-myc immunopositivity correlated with Ki-67 proliferation indices.
Conclusions:
- C-myc expression is associated with meningioma malignancy.
- C-sis/PDGF does not appear to be a reliable indicator of meningioma grade.
- C-myc may serve as a potential biomarker for meningioma progression.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Anaphase Promoting Complex
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
